MAPT and Alzheimer disease: Alzheimer’s disease brain homogenates led to increased Aβ and tau deposition in APP/PS1dE9 and Tau30+/+ mice (p = 0.009 and p = 0.0007, respectively, Additional file 5: Figure S4a-f).